Unknown

Dataset Information

Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas.


ABSTRACT:

Background

The interleukin-13 receptor alpha 2 (IL13RA2) and ephrin type A receptor 2 (EPHA2) are attractive therapeutic targets, being expressed in ~90% of canine and human gliomas, and absent in normal brain. Clinical trials using an earlier generation IL-13 based cytotoxin showed encouraging clinical effects in human glioma, but met with technical barriers associated with the convection-enhanced delivery (CED) method. In this study, IL-13 mutant and ephrin A1 (EFNA1)-based bacterial cytotoxins targeted to IL13RA2 and EPHA2 receptors, respectively, were administered locoregionally by CED to dogs with intracranial gliomas to evaluate their safety and preliminary efficacy.

Methods

In this phase I, 3 + 3 dose escalation trial, cytotoxins were infused by CED in 17 dogs with gl

SUBMITTER: Rossmeisl JH 

PROVIDER: S-EPMC7992889 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature